Sunrest Lifescience share price
You have to be logged in to add this to Watchlist.- ₹30.50(1.50%)January 22, 2026 09:50:37 AM IST
- NSE
- BSE
- Vol : 3.20 K (NSE + BSE)Last 20 day avg : 4.24 K
Sunrest Lifescience is trading 1.50% upper at Rs 30.50 as compared to its last closing price. Sunrest Lifescience has been trading in the price range of 32.00 & 30.50. Sunrest Lifescience has given -26.59% in this year & -6.44% in the last 5 days. Sunrest Lifescience has TTM P/E ratio 9.66 as compared to the sector P/E of 22.37.Listed peers of Sunrest Lifescience include Aurobindo Pharma (0.06%), Neuland Laboratories (-1.44%), Pfizer (-1.19%).The Mutual Fund holding in Sunrest Lifescience was at -% in . The MF holding has - from the last quarter. The FII holding in Sunrest Lifescience was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jan 23, 2026, 04:49 AM UTC
- Debt To EquityHigher than industry0.74The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation0.17The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | Neutral | 1,146.25 | 0.06 | 66,597.64 | 18.99 | 2.03 | 0.35 | 5.52 |
| Neuland Laboratories | Bearish | 13,416.25 | -1.44 | 17,352.88 | 83.68 | 11.43 | 0.09 | 7.17 |
| Pfizer | Bearish | 4,667.00 | -1.19 | 21,377.85 | 33.42 | 5.05 | 0.75 | 1.60 |
| Unichem Laboratories | Bearish | 382.70 | 1.10 | 2,694.43 | 19.86 | 1.1 | - | 3.51 |
| Jagsonpal Pharmaceuticals | Bearish | 170.50 | 3.36 | 1,136.56 | 29.16 | 4.76 | 1.45 | 3.18 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-13 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-05-27 | Audited Results |
| 2024-11-14 | Quarterly Results |
| 2024-05-27 | Audited Results |
- IndustryMajor Drugs
- ISININE0PLZ01012
- BSE Code
- NSE CodeSUNREST
Sunrest Lifescience is trading at 30.50 as on Thu Jan 22 2026 04:20:37. This is 1.50% upper as compared to its previous closing price of 30.50.
The market capitalization of Sunrest Lifescience is 13.09 Cr as on Thu Jan 22 2026 04:20:37.
The 52 wk high for Sunrest Lifescience is 75.00 whereas the 52 wk low is 29.55
Sunrest Lifescience can be analyzed on the following key metrics -
- TTM P/E: 9.66
- Sector P/E: 22.37
- Dividend Yield: 0.00%
- D/E ratio: 0.94
Sunrest Lifescience reported a net profit of 2.01 Cr in 2025.
EQUITY QUICK LINKS
Sunrest Lifescience QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.